Document:

Amendment to API Commercial Supply Agreement

 Exhibit 10.6 
 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND
EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. 
  

 
 AMENDMENT TO API COMMERCIAL
SUPPLY AGREEMENT 
 This AMENDMENT TO API COMMERCIAL SUPPLY
AGREEMENT (the “Amendment”) is made as of this 4 day of April, 2012 (the “Amendment Effective Date”), by and between Amarin Pharmaceuticals Ireland Ltd., a corporation organized under the laws of Ireland and having
its principal office at First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4, Ireland (“Amarin”), and Chemport Inc., a corporation organized under the laws of South Korea and having its principal offices at 15-1,
Dongsu-dong, Naju-si, Jeollanam-do 520-330 Korea (“Chemport”). 
 WHEREAS, the Parties entered into that certain API
Commercial Supply Agreement as of May 25, 2011 (the “Agreement”); and 
 WHEREAS, the Parties wish to amend the
Agreement as set forth herein. 
 NOW THEREFORE, in consideration of the premises and mutual covenants herein below, and for
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 1. Capitalized terms used but not defined herein shall have the meanings given to them in the Agreement. 
 2. A new Section 9.5 is hereby added to the Agreement and shall hereafter read as follows: 
 9.5 Amarin Representative. Amarin shall be allowed to have, at its expense, an employee of Amarin or a third party consultant present at all locations [***] for the purpose of [***]. Such employee
or third party consultant shall execute a reasonable confidentiality agreement intended to protect Confidential Information of Chemport. Chemport will reasonably cooperate in enabling such employee or consultant of Amarin to carry out his or her
activities [***]. The Amarin employee or consultant shall be obligated to follow reasonable rules and procedures made known to such employee and consultant and that apply generally to personnel of Chemport. Chemport agrees to [***]. This
Section 9.4 shall expire upon approval of the Drug Application by the FDA. 

 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE
VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. 

 
  
 3. Section 11.4 of the Agreement is deleted in its entirety and replaced with the following: 
 11.4 Special Indemnity. In the event this Agreement is terminated by Amarin pursuant to Sections 15.5(a) or (h), Chemport shall pay to Amarin the amount of [***], which shall be Amarin’s sole
and exclusive remedy with respect thereto, and in the event this Agreement is terminated by Amarin pursuant to Section 15.5(g), Chemport shall pay to Amarin the amount of [***], which shall be Amarin’s sole and exclusive remedy with
respect thereto. 
 4. A new subsection (h) is hereby added to Section 15.5 of the Agreement and shall hereafter read
as follows: 
 (h) [***]. In Amarin’s reasonable judgment, Chemport [***] on Schedule 15.5(h) hereto
at the Facility on or before [***]; provided, however, that notwithstanding anything in this Section 15.5 to the contrary, such termination shall take immediate effect upon written notice from Amarin. 

5. Schedule 15.5(h) attached hereto is hereby incorporated into the Agreement as Schedule 15.5(h). 

6. This Amendment and any other future amendment of the Agreement may be executed in two (2) or more counterparts, each of which
shall be an original, but all of which together shall constitute one and the same instrument. To evidence the fact that it has executed this Amendment and any other future amendment of the Agreement, a Party may send a copy of its executed
counterpart to the other Parties by facsimile transmission or by email transmission in portable document format, or similar format. Signatures of the Parties transmitted by facsimile or by email transmission in portable document format, or similar
format, shall be deemed to be their original signatures for all purposes. 
 7. Except as expressly provided in this Amendment,
all other provisions of the Agreement shall remain unmodified and in full force and effect. 
 [signature page follows]

  
 2 

 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE
VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. 

 
  
 [Signature Page to Amendment to API Commercial Supply Agreement] 
 IN WITNESS
WHEREOF, the Parties have caused their duly authorized representative to execute this Amendment effective as of the Amendment Effective Date. 
  

			
	AMARIN PHARMACEUTICALS IRELAND LTD.
		
	By:	 	/s/ Thomas G. Lynch
	 Name:
 Title:
	 	 Thomas G. Lynch
 Director +
Officer

  
  

			
	CHEMPORT INC.
		
	By:	 	/s/ Young Joo Kim
	 Name:
 Title:
	 	 Young Joo Kim

CEO/President

  

 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE
VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. 

 
  
 SCHEDULE 15.5(H) 
 [***]FORM OF PERFORMANCE STOCK UNITS GRANT NOTICE [2012

 EXHIBIT 10.3 

 

			
	 FORM OF SPECIAL PERFORMANCE STOCK UNITS

GRANT NOTICE [2012]
	  	 [FHN logo]

              Special Performance
Stock Units 
 [name] 

You have been granted special Performance Stock Units (PSUs) of First Horizon National Corporation as follows: 

 

											
	 GRANT DATE:
	  	 	  	 	GOVERNING PLAN:	  	  	Equity Compensation Plan	  	 
	 NUMBER OF PSUs

GRANTED:
	  	 _________ units
	  	 

 
	PERFORMANCE
 PERIOD:
	  

  
	  	 5-year period ending on the Vesting

Date
	  	 
	 GRANT DATE STOCK

PRICE:
	  	$ _____ per share  	  	 	VESTING DATE:	  	  	[5th
 anniversary of Grant Date]	  	 

 This PSU award is granted under the Governing Plan specified above, and is governed by the terms and
conditions of that Plan and by policies, practices, and procedures (“Procedures”) of the Compensation Committee (that administers the Plan) that are in effect during the performance and vesting periods. This is a Section 10 Award
under the Plan. This award is subject to the terms and restrictions of FHNC’s stock ownership guidelines and Compensation Recovery Policy (“Policy”) as in effect during the vesting period. 

PSUs are not shares of stock and are not transferable. Each PSU that vests will result in one share of FHNC common stock being issued to
you, subject to withholding for taxes, as provided in Exhibit A. Subject to provisions of the Governing Plan, the Committee may choose to pay all or a portion of vested PSUs in cash, based on the fair market value of vested shares on the Vesting
Date. 
 PSUs that have not been forfeited prior to the Vesting Date will have “performed” if either performance goal
for this award is achieved during the Performance Period, all as set forth in Exhibit A to this Notice. Performance for this award in Exhibit A is based on achievement of either a specified stock price, or a specified total shareholder return,
during the Performance Period. PSUs that do not perform by the Vesting Date automatically are forfeited on the Vesting Date. 

This PSU award also is subject to possible reduction or forfeiture in advance of vesting in accordance with the Governing Plan, the
Procedures, and the Policy. As of the Grant Date, the Procedures provide (among other things) that: (a) forfeiture generally will occur immediately upon termination of employment — you must remain continuously employed by FHNC or one of
its subsidiaries through the close of business on the vesting date; but (b) if your termination of employment occurs because of your death or permanent disability, the PSUs will be partially forfeited in proportion to the part of the
Performance Period during which you are not employed, as determined by the Committee. The reduced PSUs will vest or not vest based on achievement of performance goals over the entire Performance Period. 

If a Change in Control (as defined in the Governing Plan) occurs, this PSU award is subject to reduction as provided in Exhibit A.
Following a Change in Control, if you experience a Qualifying Termination of your employment the portion of this award then outstanding will vest and be paid as provided in the Governing Plan. 

Currently the Plan and Policy provide for forfeiture of PSUs or recovery of PSU proceeds if you engage in certain types of misconduct or
if reported data which impacts performance is materially false or misleading and you are substantially responsible for its accuracy. 
 This PSU award will be forfeited, or if already vested you must pay in cash to FHNC the gross pre-tax value of the award measured at vesting, if during the restriction period applicable to this award you,
acting on your own behalf or acting on behalf of or in concert with any other person or entity, in any manner directly or indirectly: (i) compete with, or become an officer, employee, director, agent, advisor, consultant, or more-than-5% owner
of any competitor of, FHNC or any of its subsidiaries; (ii) disparage or embarrass FHNC or any of its subsidiaries, policies, practices, products, officers, directors, or employees in any manner whatsoever; (iii) disclose to anyone any
confidential, proprietary, or other non-public information concerning FHNC, any of its subsidiaries, or any of their customers, officers, directors, or employees; or (iv) solicit, hire, or encourage any person who is then an employee or
customer of FHNC or any and all of its subsidiaries or affiliates to leave the employment of, or to end, diminish, or move any of his, her, or its accounts or relationships with, FHNC or any and all of its subsidiaries or affiliates. The restriction
period for this award begins on the Grant Date and ends on the second anniversary of the Vesting Date. By accepting this PSU award, you acknowledge that FHNC may reduce or offset other amounts owed to you, including but not limited to wages or
commissions owed, among other things, to satisfy any repayment obligation. 

 Your PSUs will accrue cash dividend equivalents, to the extent cash dividends are paid on
common shares prior to vesting. From the Grant Date until the Vesting Date, dividend equivalents accumulate (without interest) as if each PSU were an outstanding share. To the extent that PSUs vest, the accumulated dividend equivalents associated
with vested PSUs will be paid in cash at vesting or in the next payroll cycle. Dividend equivalents associated with forfeited PSUs likewise are forfeited. Stock splits and stock dividends will result in a proportionate adjustment to the number of
PSUs as provided in the Plan and Procedures. 
 Vesting is a taxable event for you. Your withholding and other taxes will depend
upon FHNC’s stock value on the vesting date and the amount of dividend equivalents paid to you. As of the Grant Date, the Committee’s Procedures provide that FHNC will withhold shares and cash at vesting in the amount necessary to cover
your required withholding taxes; however, the Procedures may be changed at any time. You are not permitted to make any election in accordance with Section 83(b) of the Internal Revenue Code of 1986, as amended, to include in your gross income
for federal income tax purposes the value of the PSUs this year. If you make a Section 83(b) election, it will result in the forfeiture of your PSUs. 
 Questions about your PSU award? 
 Important information concerning the
Governing Plan and this PSU award is contained in a prospectus. Copies of the current prospectus (including all applicable supplements) are delivered separately, and you may request a copy of the Plan or prospectus at any time. If you have questions
about your PSU grant or need a copy of the Governing Plan, the related prospectus, or the Committee’s current administrative procedures, contact Fidelity Investment’s Executive Relationship Officer at
            . For all your personal stock incentive information, you may view your award and other information on Fidelity’s website at www.NetBenefits.com. 

[Managing Your Money Logo]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]